2021
DOI: 10.1038/s41563-021-01042-y
|View full text |Cite
|
Sign up to set email alerts
|

Microenvironment-triggered multimodal precision diagnostics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
30
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 51 publications
(31 citation statements)
references
References 48 publications
1
30
0
Order By: Relevance
“…Importantly, this strategy has been shown to outcompete conventional FDG-based PET imaging by showing clear detection of occult malignant in tumor-bearing mice while reducing false positive detection rates of inflammation in non-cancerous mouse models. Similar observations have been made with a pH-dependent peptide pHLIP that allows the specific release of the 64 Cu radiotracer in acidic (tumor) tissues and the detection of primary and metastatic lesions in mouse models of CRC (Hao et al, 2021). In this study, the authors have also reported that this approach can monitor the therapeutic response to 5-FU, a standard chemotherapy for CRC.…”
Section: Implementing Tumor Metabolic Profiling For Clinical Decision...supporting
confidence: 71%
“…Importantly, this strategy has been shown to outcompete conventional FDG-based PET imaging by showing clear detection of occult malignant in tumor-bearing mice while reducing false positive detection rates of inflammation in non-cancerous mouse models. Similar observations have been made with a pH-dependent peptide pHLIP that allows the specific release of the 64 Cu radiotracer in acidic (tumor) tissues and the detection of primary and metastatic lesions in mouse models of CRC (Hao et al, 2021). In this study, the authors have also reported that this approach can monitor the therapeutic response to 5-FU, a standard chemotherapy for CRC.…”
Section: Implementing Tumor Metabolic Profiling For Clinical Decision...supporting
confidence: 71%
“…Human beings have suffered from serious diseases, like cancers and cardiovascular diseases for centuries. [1][2][3] Numerous techniques in the disciplines of precision diagnostics, 4,5 targeted therapy, 6,7 intraoperative imaging 8,9 and postoperative evaluation 10,11 have been developed and applied to improve disease outcomes. The rapid development of exceptional materials is critical to new technology innovation in the biomedical field.…”
Section: Introductionmentioning
confidence: 99%
“…By rationally integrating different imaging agents, nanoprobes can be tailored to have versatile properties for multimodal imaging, which could compensate for the weaknesses of each imaging modality [ 1 , 16 , 17 ]. FI brings the capability to identify tumor-associated biomarkers with high sensitivity [ 18–20 ].…”
Section: Introductionmentioning
confidence: 99%